Skip to content

Effect of laparoscopic preservation of pylorus and vagus nerve on postoperative quality of life in patients with early gastric cancer: a randomized controlled trial

Effect of laparoscopic preservation of pylorus and vagus nerve on postoperative quality of life in patients with early gastric cancer: a randomized controlled trial

Status
Active, not recruiting
Phases
Early Phase 1
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2000036380
Enrollment
Unknown
Registered
2020-08-22
Start date
2020-10-01
Completion date
Unknown
Last updated
2020-09-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

gastric cancer

Interventions

1:Laparoscopic pylorus preserving radical gastrectomy for gastric cancer
2:Laparoscopic distal gastrectomy and anastomosis

Sponsors

Renji Hospital, Shanghai Jiao Tong University School of Medicine
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 75 Years

Inclusion criteria

Inclusion criteria: 1. Aged 18 to 75 years old; 2. The primary gastric lesion was diagnosed as gastric adenocarcinoma by biopsy; 3. The preoperative clinical stage was T1N0M0 according to ajcc-7thtnm; 4. It is expected that pylorus preserving gastrectomy and D1 + lymph node dissection can obtain R0; 5. Preoperative ECoG physical status score was 0 / 1; 6. Preoperative ASA score I - III; 7. Patients' informed consent.

Exclusion criteria

Exclusion criteria: 1. Pregnant or lactating women with severe mental illness; 2. History of upper abdominal surgery (except laparoscopic cholecystectomy); 3. History of gastric surgery (including ESD / EMR for gastric cancer); 4. Preoperative imaging examination showed regional enlarged lymph nodes; 5. He had a history of other malignant diseases within 5 years; 6. Patients with gastric cancer who have received or recommended neoadjuvant therapy; 7. There was a history of unstable angina pectoris or myocardial infarction within 6 months; 8. There was a history of cerebral infarction or cerebral hemorrhage within 6 months; 9. There was a history of continuous systemic corticosteroid treatment within 1 month; 10. Other diseases need surgical treatment at the same time; 11. Gastric cancer complicated with complications (bleeding, perforation, obstruction) and required emergency surgery; 12. FEV1 of pulmonary function test was less than 50% of the predicted value.

Design outcomes

Primary

MeasureTime frame
quality of life;

Countries

China

Contacts

Public ContactZhao Gang

Shanghai Jiao Tong University

xiangmoumou@163.com+86 13651810987

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026